Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
2.650
-0.180 (-6.36%)
At close: Jul 14, 2026, 4:00 PM EDT
2.620
-0.030 (-1.13%)
After-hours: Jul 14, 2026, 7:49 PM EDT
Adial Pharmaceuticals Market Cap
Adial Pharmaceuticals has a market cap or net worth of $5.68 million as of July 14, 2026. Its market cap has increased by 7.45% in one year.
Market Cap
5.68M
Enterprise Value
1.10M
1-Year Change
7.45%
Ranking
Category
Stock Price
$2.65
Market Cap Chart
Since July 30, 2018, Adial Pharmaceuticals's market cap has decreased from $26.33M to $5.68M, a decrease of -78.43%. That is a compound annual growth rate of -17.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 5.68M | -3.11% |
| Dec 31, 2025 | 5.86M | -10.34% |
| Dec 31, 2024 | 6.54M | 188.66% |
| Dec 29, 2023 | 2.27M | -60.76% |
| Dec 30, 2022 | 5.77M | -89.79% |
| Dec 31, 2021 | 56.55M | 131.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 30, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 6.36M |
| BioAtla | 6.34M |
| Curanex Pharmaceuticals | 6.32M |
| Pulmatrix | 6.28M |
| Xenetic Biosciences | 6.27M |
| AIM ImmunoTech | 6.25M |
| Purple Biotech | 6.20M |
| Silo Pharma | 6.18M |